ZEPBOUNDEli Lillys Weight Loss Medication Contender Originally developed for type 2 diabetes, ZEPBOUND (tirzepatide), Eli Lilly weight loss medication, is now making waves in obesity treatment
Sustaining Wellness Through Food While semaglutide offers benefits for managing weight and diabetes, proper nutrition remains vital to maintaining health
Over a 72 week period, patients can experience losing up to 1520% of their body weight
doi: 10.1001/jama.2023.24945 107 BucheitJAyersJPamulapatiLBrowningASissonEA
Clinically, it may be particularly helpful in patients with: Wheezing or respiratory symptoms Persistent hives or itching Abdominal cramping related to smooth muscle activation Studies in chronic idiopathic urticaria have shown that montelukast may reduce itch severity and hive frequency in some patients, particularly when used as adjunctive therapy
But I hope for Hims & Hers sake it was able to look past the short term cash cow (and its very clear theyve seen tons of growth from the weight loss segment as well as the cross sell potential there into other verticals), as the other segments of the business are doing great, and its a solid, growing business